People · Operator
Named in public records as an officer, director or promoter · active 2010–2022 · Other Health Care, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Emerging Therapy Solutions, Inc. | — | Other Health Care | Series A | $24.3M | $26.9M | 2018 |
| Mosaic Biosciences, Inc. | — | Biotechnology | Series A | $14.7M | $176.4M | 2022 |
| Medpricer.Com Inc | — | Other Technology | Series A | $5.2M | $138.7M | 2010 |
Jeanette Welsh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeanette Welsh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Augustine Lawlor | 1 | 8 |
| Kevin Roche | 1 | 6 |
| Mark Lupa | 1 | 5 |
| David McLean | 1 | 5 |
| Nassim Usman | 1 | 4 |
| J. Matthew Mackowski | 1 | 4 |
| Eric Furfine | 1 | 3 |
| Guy Katsav | 1 | 3 |
| Dan Mitchell | 1 | 2 |
| Nathan Schmidt | 1 | 2 |
| Rob Capone | 1 | 2 |
| Ravi Nalliah | 1 | 1 |
| Matt Mackowski | 1 | 1 |
| Lester Grant, Jr. | 1 | 1 |
| Lester Grant, Sr. | 1 | 1 |
| Christopher Durbin | 1 | 1 |
| Robert C. Hart | 1 | 1 |
| Matthew Mackowski | 1 | 1 |
| Gui Karyo | 1 | 1 |
| Martin Stanton | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.